Back
Compare AU
Compare DRIV vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares Electric Vehicles and Ftr Mobility ETF (DRIV) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRIV | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 74 | 71 |
Median incremental investment | $994.73 | $745.07 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,439.06 | $2,057.92 |
Average age group | > 35 | > 35 |
Key Summary
DRIV | DRUG | |
|---|---|---|
Strategy | DRIV.AX was created on 2021-12-13 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. DRIV.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to a portfolio of global companies at the forefront of innovation in automotive technology | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | KRW - KOREAN WON (0 %) VOLVO AB (8.91 %) PACCAR INC (8.36 %) | BRL - BRAZILIAN REAL (0 %) AUD - AUSTRALIA DOLLAR (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Other (59.52 %) Consumer Discretionary (20.25 %) Industrials (11.65 %) | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) |
Top 3 countries | United States (39.24 %) China (16.43 %) Germany (13.71 %) | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) |
Management fee | 0.67 % | 0.57 % |
Key Summary
DRIV | DRUG | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Solactive Future Mobility Index - AUD - Benchmark TR Net | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.67 % | 0.57 % |
Price | $10.75 | $8.76 |
Size | $16.202 million | $181.588 million |
10Y return | N/A | 75.90 % |
Annual distribution yield (5Y) | 1.09 % | 1.82 % |
Market | ASX | ASX |
First listed date | 14/12/2021 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRIV | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 74 | 71 |
Median incremental investment | $994.73 | $745.07 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,439.06 | $2,057.92 |
Average age group | > 35 | > 35 |
Pros and Cons
DRIV | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRIV | DRUG |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |